StockData
USANA Health Sciences Inc logo

USANA Health Sciences Inc (USNA) income statement

USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.22−0.35 (-2.58%)

Close on Nov 18, 2026Market cap $244.26MP/E –Yield –

USANA Health Sciences Inc income statement

Ratios

Latest available, balances at Jul 4, 2026

Profitability, TTM

Gross margin
77.4%
Operating margin
-0.1%
Net margin
-2.4%
Return on equity, FY2025
2.0%

Financial strength

Current ratio
2.66
Debt to equity
–
Debt to assets
–
Cash to current liabilities
159.5%

Valuation

P/E ratio
–
Price to sales
0.27
Price to book
0.46
Dividend yield
–

See a number that looks wrong?